
Would Wider Access to GLP-1s Throttle Addiction?
Cato Daily Podcast
Exploring the Off-Label Use of GLP-1 Drugs in Addiction Treatment
This chapter explores the careful approach required in using GLP-1 drugs for addiction treatment, focusing on ongoing research related to their effectiveness and safety. It also discusses off-label prescribing and its impacts on patients, emphasizing the need for further clinical trials as these medications gain traction for uses outside traditional diabetes and obesity treatment.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.